Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease | MicrobiomeTrials← Back to trialsNCT07556718
Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-03Est. Completion: 2029-12
Enrollment target: 100 participants Locations- University of Michigan, Ann Arbor, Michigan, United States
Other microbiome trials you might be interested in
IBD (Inflammatory Bowel Disease)IBS (Irritable Bowel Syndrome)
The medical management of inflammatory bowel disease (IBD) has evolved over the years thanks to the newly available ther…
Rome, ItalyCompleted Dec 1, 2025
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative ColitisIndeterminate ColitisFunctional Abdominal Pain SyndromeFunctional Bowel DisorderEsophageal DiseasesGastroduodenal Disorder
Bowel Dysfunction
Gallbladder Diseases
Sphincter of Oddi Dysfunction
Anorectal Disorder
This is a prospective observational study collecting long-term clinical data and samples for research in pediatric infla…
Seattle, United StatesEst. completion Jan 2028